Skip to main content
Premium Trial:

Request an Annual Quote

California Clears Decode Genetics' Clinical Lab

NEW YORK (GenomeWeb News) — The State of California has cleared Decode Genetics to market its genotyping tests to the state’s physicians and residents by giving the company a clinical laboratory license, Decode said today.

The state had forbidden Decode and a number of other firms from offering genetic tests directly to consumers last summer. At the time, California officials said that these companies were not in compliance with state law governing lab compliance and certification and that there were concerns about physician oversight of the services.

Decode CEO Kari Stefansson said in a statement today that the company is unique in that it discovers genetic risk factors for common diseases and brings to market reference lab tests and DTC scans. "Our competitors outsource the science, the DNA-analysis, or both," he said. "But for us this is the real foundation of personalized medicine."

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.